Association between Vitamin D status and COVID-19 antibody titer in patients with hemodialysis

Association between Vitamin D status and COVID-19 antibody titer in patients with hemodialysis - Association between Vitamin D status and COVID-19 antibody titer in patients with hemodialysis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000046906

Enrollment

400

Registered

2022-02-14

Start date

2022-01-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 infection

Interventions

COVID-19 vaccine (BNT162b2)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The participants are older than 20 years of age, and regularly received thrice-weekly hemodialysis. In addition, the participants are those who obtained written, informed consent.

Exclusion criteria

Exclusion criteria: This study exclude patients who do not have enough judgment ability, can not write questionnaire, and are current illness worsens.

Design outcomes

Primary

Measure	Time frame
COVID-19 antibody titer	—

Countries

Japan

Contacts

Public ContactNakashima Akio

Jikei University School of Medicine Division of Nephrology and Hypertension, Department of Internal Medicine

a-nakashima@jikei.ac.jp03-3411-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026